Hikma Pharmaceuticals was fined $4,400 by the Ohio EPA for hazardous waste violations. The company shipped a mislabeled tote of corrosive cleaning chemical to a facility unauthorized to handle ...

Hikma Pharmaceuticals PLC HIK shares dropped 1.41% to £20.98 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to ...

“Hikma said in its SCOTUS petition that the CAFC’s decision ‘effectively nullifies a statutory mechanism for expediting access to generic drugs and breaks sharply with precedent on ...

Hikma’s operational development across its manufacturing facilities has resulted in strong EBITDA margins of above 25% in the last decade. Fitch projects a defined EBITDA margin of close to 25% ...

About Hikma. Hikma helps put better health within reach every day for millions of people around the world. For more than 45 years, we've been creating high-quality medicines and making them accessible ...

Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed) 06/03/2025: DISTRIBUTED for Conference of 6/18/2025. 06/23/2025: The Solicitor General is invited to file a brief in ...

Pharmalittle: We’re reading about a top FDA official leaving, Sen. Cassidy challenging RFK Jr., and more ...

Bio-Thera Solutions, Ltd, a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary ...

They underscore Hikma’s solid market position across key geographies and reflect confidence in our ability to consistently deliver strong financial results, supported by our diversified business ...